News >

Expert Sheds Light on Rapid Progress in Relapsed/Refractory Myeloma

Caroline Seymour
Published: Tuesday, Oct 08, 2019

Ivan M. Borrello, MD

Ivan M. Borrello, MD

Given the number of treatment regimens that have become available to patients with relapsed/refractory multiple myeloma, the decision of which strategy to pursue should be grounded in the nature of the relapse, the setting in which it occurs, and any comorbidities that may present contraindications to specific agents, explained Ivan M. Borrello, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication